project id: TCGA-PRAD; case submitter id: TCGA-XQ-A8TA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 8.3; age at index: 59; days to birth: -21889; days to death: 146; ethnicity: hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1953; year of death: 2012; age at diagnosis: 21889; ajcc clinical m: M1b; ajcc clinical t: T3a; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 5; prior malignancy: no; prior treatment: Yes; progression or recurrence: not reported; secondary gleason grade: Pattern 5; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 601; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-XQ-A8TA-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;